beta blocker in heart failure new
DESCRIPTION
Prevalensi heart failureTRANSCRIPT
![Page 1: Beta Blocker in Heart Failure New](https://reader036.vdocuments.site/reader036/viewer/2022083011/55cf85a4550346484b903769/html5/thumbnails/1.jpg)
Beta Blocker in Heart Failure
Dr Muh.Yusuf Suseno,SpJP
![Page 2: Beta Blocker in Heart Failure New](https://reader036.vdocuments.site/reader036/viewer/2022083011/55cf85a4550346484b903769/html5/thumbnails/2.jpg)
Why look at Heart Failure?
• It is a serious health problem with significant morbidity and mortality
• It is often misdiagnosed• It is under-investigated• It is under-treated• It is an area of rapid development with a
good evidence base
Horne et al, Barriers to optimum management of heart failure by general practitioners, Br J Gen Pract1999
![Page 3: Beta Blocker in Heart Failure New](https://reader036.vdocuments.site/reader036/viewer/2022083011/55cf85a4550346484b903769/html5/thumbnails/3.jpg)
What are we going to look at?
• Incidence and prevalence• Diagnosis • Prognosis• Treatment in primary care• Barriers• Some problems –what do GPs want?• Anything else you want to discuss
•
![Page 4: Beta Blocker in Heart Failure New](https://reader036.vdocuments.site/reader036/viewer/2022083011/55cf85a4550346484b903769/html5/thumbnails/4.jpg)
Incidence and PrevalenceAn Average Surgery
•Common
–Prevalence 1-2% in general population
–10-20% in very elderly
–Average GP sees ~5-10 new cases / year and have ~ 20-40 CHF patients on record
•Costly
–1-2% of NHS expenditure, 70% of which due to hospitalisation ( in SE London £ 10.2 million)
“Heart Failure is common and costly”